AKT1 and cancer: Thus, overall, our experimental findings clearly indicated that the anti-cancer effects of plumbagin in HCC are mediated through the mitigation of PI3K/AKT signaling cascade and thus provide a strong rationale for pursuing the use of plumbagin in the treatment of HCC and other malignancies where angiogenesis is the key contributor to disease progression.